Published in Am J Cancer Res on December 01, 2016
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature (2010) 22.04
miRNAs in human cancer. J Pathol (2010) 6.02
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 6.00
MicroRNAs and cancer. Semin Cancer Biol (2003) 4.72
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res (2005) 3.41
MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab (2008) 3.40
SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J Biol Chem (1999) 3.35
Current treatment of osteosarcoma. Cancer Invest (2001) 2.20
Osteosarcoma in preadolescent patients. Clin Orthop Relat Res (2000) 1.20
EMT transcription factors: implication in osteosarcoma. Med Oncol (2013) 1.08
Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo. Cancer Sci (2014) 1.06
miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro. Clin Cancer Res (2012) 1.04
Big effects of small RNAs: a review of microRNAs in anxiety. Mol Neurobiol (2012) 1.04
MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem Biophys Res Commun (2013) 1.04
Potential of microRNAs for cancer diagnostics, prognostication and therapy. Curr Opin Oncol (2012) 1.03
MicroRNAs and Potential Targets in Osteosarcoma: Review. Front Pediatr (2015) 0.98
Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell Biochem Biophys (2014) 0.88
miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncol Rep (2015) 0.88
microRNA and Bone Cancer. Adv Exp Med Biol (2015) 0.86
MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer. PLoS One (2015) 0.86
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules (2016) 0.84
MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition. Onco Targets Ther (2016) 0.81
miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2. Oncol Lett (2016) 0.80
MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. Oncotarget (2016) 0.80
MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Oncotarget (2016) 0.80
MicroRNA-187 induces diffuse large B-cell lymphoma cell apoptosis via targeting BCL6. Oncol Lett (2016) 0.78
[Expressions of ZEB2 and C-myc in epithelial ovarian cancer and their clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao (2015) 0.77
Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Oncotarget (2016) 0.77
miR-187-5p Regulates Cell Growth and Apoptosis in Acute Lymphoblastic Leukemia via DKK2. Oncol Res (2016) 0.77
MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1. Biochem Biophys Res Commun (2016) 0.76